4WEB Medical, provider of 3-D printed orthopedic implants, announced its first Australian patient-specific implant surgery. Supported by 4WEB's Australian partner, LifeHealthcare, the 4WEB patient-specific segmental bone defect procedure was completed the week of July 20 in Brisbane, Australia.

Mevion Medical Systems announced today that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion. The investment was led by HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and existing U.S. investors Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Concurrent with the investment, Mevion and the lead investors will form a joint venture in China to produce, sell and service proton therapy systems for the Chinese market. HOPU and YuanMing have extensive experience investing in successful healthcare companies and offer a significant network of healthcare experience in China.